Fgf10 overexpression enhances the formation of tissue-engineered small intestine

Journal of Tissue Engineering and Regenerative Medicine

Volumn 10, Issue 2, 2016, Pages 132-139

  Torashima, Yasuhiro ^a   Levin, Daniel E ^a   Barthel, Erik R ^a   Speer, Allison L ^a   Sala, Frédéric G ^a   Hou, Xiaogang ^a   Grikscheit, Tracy C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Fgf10; Intestinal failure; Short bowel syndrome; Small intestine; Tissue engineering

Indexed keywords

CELL CULTURE; CELLS; MAMMALS; TISSUE; TISSUE ENGINEERING;

'CURRENT; CONDITION; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 10; INTESTINAL FAILURE; OVEREXPRESSIONS; SHORT BOWEL SYNDROME; SMALL INTESTINE; SURFACE AREA; TISSUES ENGINEERINGS;

HISTOLOGY;

BETA GALACTOSIDASE; DOXYCYCLINE; FIBROBLAST GROWTH FACTOR 10; FGF10 PROTEIN, MOUSE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DUODENUM; ENTEROENDOCRINE CELL; FGF10 GENE; GENE OVEREXPRESSION; GOBLET CELL; ILEUM; INTESTINE CELL; INTESTINE CRYPT; INTESTINE EPITHELIUM CELL; INTESTINE VILLUS; JEJUNUM; MESENCHYME; MOUSE; NONHUMAN; OMENTUM; PANETH CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMALL INTESTINE; SMALL INTESTINE MUCOSA; TISSUE ENGINEERED SMALL INTESTINE; TISSUE ENGINEERING; ANIMAL; CYTOLOGY; INTESTINE MUCOSA; METABOLISM; ORGAN SIZE; PROCEDURES; TRANSGENIC MOUSE;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; FIBROBLAST GROWTH FACTOR 10; INTESTINAL MUCOSA; INTESTINE, SMALL; MICE, TRANSGENIC; ORGAN SIZE; TISSUE ENGINEERING;

EID: 84957848628     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1720     Document Type: Article

References (31)

1. Barthel ER, Speer AL, Levin DE, et al. 2012; Tissue engineering of the intestine in a murine model. J Vis Exp 70: e4279.
2. Bellusci S, Grindley J, Emoto H, et al. 1997; Fibroblast growth factor 10 (FGF10) and branching morphogenesis in the embyronic mouse lung. Development 124: 4867-4878.
3. Burns R, Fairbanks T, Sala F, et al. 2004; Requirement for fibroblast growth factor 10 or fibroblast growth factor receptor 2-IIIb signaling for cecal development in mouse. Dev Biol 265: 61-74.
4. Evans GS, Flint N, Somers AS, et al. 1992; The development of a method for the preparation of rat intestinal epithelial cell primary cultures. J Cell Sci 101(1): 219-231.
5. Fairbanks T, De Langhe S, Sala F, et al. 2004; Fibroblast growth factor 10 (Fgf10) invalidation results in anorectal malformation in mice. J Pediatr Surg 39: 360-365.
6. Fairbanks TJ, Sala FG, Kanard R, et al. 2006; The fibroblast growth factor pathway serves a regulatory role in proliferation and apoptosis in the pathogenesis of intestinal atresia. J Pediatr Surg 41: 132-136.
7. Fitzgibbons SC, Jones BA, Hull MA, et al. 2010; Relationship between biopsy-proven parenteral nutrition-associated liver fibrosis and biochemical cholestasis in children with short bowel syndrome. J Pediatr Surg 45: 95-99.
8. Freytes CO, Ratanatharothorn V, Taylor C, et al. 2004; Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation. Clin Cancer Res 10(24): 8318-8324.
9. Grikscheit TC, Ochoa ER, Ramsanahie A, et al. 2003a; Tissue-engineered large intestine resembles native colon with appropriate in vitro physiology and architecture. Ann Surg 238: 35-41.
10. Grikscheit T, Ochoa ER, Srinivasan A, et al. 2003b; Tissue-engineered esophagus: experimental substitution by onlay patch or interposition. J Thorac Cardiovasc Surg 126: 537-544.
11. Grikscheit TC, Siddique A, Ochoa ER, et al. 2004; Tissue-engineered small intestine improves recovery after massive small bowel resection. Ann Surg 240: 748-754.
12. Grikscheit T, Srinivasan A, Vacanti JP. 2003c; Tissue-engineered stomach: a preliminary report of a versatile in vivo model with therapeutic potential. J Pediatr Surg 38: 1305-1309.
13. Kanard RC, Fairbanks TJ, De Langhe SP, et al. 2005; Fibroblast growth factor-10 serves a regulatory role in duodenal development. J Pediatr Surg 40: 313-316.
14. Katoh M. 2006; FGF signaling network in the gastrointestinal tract. Int J Oncol 29: 163-168.
15. Kato T, Tzakis AG, Selvaggi G, et al. 2006; Intestinal and multivisceral transplantation in children. Ann Surg 243: 756-764.
16. Kelly R, Brown N, Buckingham M. 2001; The arterial pole of he mouse heart forms from Fgf10-expressing cells in pharyngeal mesoderm. Dev Cell 3: 435-440.
17. Luo J, Lin H, Lu C, et al. 2008; Dexamethasone inhibits basic fibroblast growth factor-stimulated gastric epithelial cell proliferation. Biochem Pharmacol 76: 841-849.
18. McMellen ME, Wakeman D, Longshore SW, et al. 2010; Growth factors: possible roles for clinical management of the short bowel syndrome. Semin Pediatr Surg 19: 35-43.
19. O'Brien DP, Nelson LA, Stern LE, et al. 2001; Epithelial permeability is not increased in rats following small bowel resection. J Surg Res 97: 65-70.
20. Ohuchi H, Hori Y, Yamasaki M, et al. 2000; FGF10 acts as a major ligand for FGF receptor 2 IIIb in mouse multi-organ development. Biochem Biophys Res Commun 277: 643-649.
21. Ornitz D, Itoh N. 2001; Fibroblast growth factors. Genome Biol 2: 1-12.
22. Robson MC, Phillips TJ, Falanga V, et al. 2001; Randomized rial of topically applied repifermin (recombinant human keratinocyte growth factor-2) to accelerate wound helaing in venous ulcers. Wound Repair Regen 9(5): 347-352.
23. Sala FG, Curtis JL, Veltmaat JM, et al. 2006; Fibroblast growth factor 10 is required for survival and proliferation but not differentiation of intestinal epithelial progenitor cells during murine colon development. Dev Biol 299: 373-385.
24. Sala FG, Kunisaki SM, Ochoa ER, et al. 2009; Tissue-engineered small intestine and stomach form from autologous tissue in a preclinical large animal model. J Surg Res 156: 205-212.
25. Sala FG, Matthews JA, Speer AL, et al. 2011; A multicellular approach forms a significant amount of tissue-engineered small intestine in the mouse. Tissue Eng Part A 17: 1841-1850.
26. Sandborn WJ, Sands BE, Wolf DC, et al. 2003; Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Aliment Pharmacol Ther 17(11): 1355-1364.
27. Spencer-Dene B, Sala FG, Bellusci S, et al. 2006; Stomach development is dependent on fibroblast growth factor 10/fibroblast growth factor receptor 2b-mediated signaling. Gastroenterology 130: 1233-1244.
28. Speer AL, Sala FG, Matthews JA, et al. 2011; Murine tissue-engineered epithelium demonstrates epithelial differentiation. J Surg Res 1: 6-14.
29. Tai CC, Curtis JL, Sala FG, et al. 2009; Induction of fibroblast growth factor 10 (FGF10) in the ileal crypt epithelium after massive small bowel resection suggests a role for FGF10 in gut adaptation. Dev Dyn 238: 294-301.
30. Vanderhoof JA, Langnas AN. 1997; Short-bowel syndrome in children and adults. Gastroenterology 113: 1767-1778.
31. Veltmaat JM, Relaix F, Le LT, et al. 2006; Gli3-mediated somitic Fgf10 expression gradients are required for the induction and patterning of mammary epithelium along the embryonic axes. Development 133: 2325-2335.